Product
Ripasudil
Aliases
K-321
6 clinical trials
7 indications
Indication
Corneal EdemaIndication
Primary Open Angle GlaucomaIndication
ocular hypertensionIndication
FuchsIndication
Fuchs Endothelial Corneal DystrophyIndication
Fuchs' Endothelial DystrophyIndication
Retinopathy of PrematurityClinical trial
A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Treatment and 14-week Extension, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract SurgeryStatus: Completed, Estimated PCD: 2023-06-22
Clinical trial
A Single-masked, Randomized, Multi-center, Parallel-group, 4-week Study Evaluating the Efficacy and Safety of Once Daily Netarsudil Ophthalmic Solution 0.02% Compared to Twice Daily Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% in Japanese Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)Status: Completed, Estimated PCD: 2021-07-09
Clinical trial
Descemet Endothelial Thickness Comparison Trials (DETECT I & II)Status: Recruiting, Estimated PCD: 2026-11-30
Clinical trial
A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects With Fuchs Endothelial Corneal DystrophyStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Subjects With Fuchs Endothelial Corneal DystrophyStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of PrematurityStatus: Completed, Estimated PCD: 2022-11-30